Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors-a review of research and clinical practice.

Autores: Boguszewski MCS, Cardoso-Demartini AA, Boguszewski CL, Chemaitilly W, Higham CE, Johannsson G, Yuen KCJ.
Publicado em: Pituitary. 2021;24(5):810-827. doi: 10.1007/s11102-021-01173-0.
Clique para leitura: https://pubmed.ncbi.nlm.nih.gov/34304361/